| Genetics of follicular lymphoma transformation L Pasqualucci, H Khiabanian, M Fangazio, M Vasishtha, M Messina, ... Cell reports 6 (1), 130-140, 2014 | 598 | 2014 |
| Targeting HIF1α eliminates cancer stem cells in hematological malignancies Y Wang, Y Liu, SN Malek, P Zheng, Y Liu Cell stem cell 8 (4), 399-411, 2011 | 482 | 2011 |
| Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types S Jones, M Li, DW Parsons, X Zhang, J Wesseling, P Kristel, MK Schmidt, ... Human mutation 33 (1), 100-103, 2012 | 349 | 2012 |
| Tandem SH2 domains of ZAP-70 bind to T cell antigen receptor zeta and CD3 epsilon from activated Jurkat T cells. RL Wange, SN Malek, S Desiderio, LE Samelson Journal of Biological Chemistry 268 (26), 19797-19801, 1993 | 348 | 1993 |
| Targeting MLL1 H3K4 methyltransferase activity in mixed-lineage leukemia F Cao, EC Townsend, H Karatas, J Xu, L Li, S Lee, L Liu, Y Chen, ... Molecular cell 53 (2), 247-261, 2014 | 320 | 2014 |
| Loss of the HVEM tumor suppressor in lymphoma and restoration by modified CAR-T cells M Boice, D Salloum, F Mourcin, V Sanghvi, R Amin, E Oricchio, M Jiang, ... Cell 167 (2), 405-418. e13, 2016 | 258 | 2016 |
| Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14 P Ouillette, H Erba, L Kujawski, M Kaminski, K Shedden, SN Malek Cancer research 68 (4), 1012-1021, 2008 | 246 | 2008 |
| Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma H Li, MS Kaminski, Y Li, M Yildiz, P Ouillette, S Jones, H Fox, K Jacobi, ... Blood, The Journal of the American Society of Hematology 123 (10), 1487-1498, 2014 | 200 | 2014 |
| Activating STAT6 mutations in follicular lymphoma M Yildiz, H Li, D Bernard, NA Amin, P Ouillette, S Jones, K Saiya-Cork, ... Blood, The Journal of the American Society of Hematology 125 (4), 668-679, 2015 | 178 | 2015 |
| Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia B Parkin, P Ouillette, Y Li, J Keller, C Lam, D Roulston, C Li, K Shedden, ... Blood, The Journal of the American Society of Hematology 121 (2), 369-377, 2013 | 147 | 2013 |
| Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia P Ouillette, R Collins, S Shakhan, J Li, E Peres, L Kujawski, M Talpaz, ... Blood, The Journal of the American Society of Hematology 118 (11), 3051-3061, 2011 | 141 | 2011 |
| The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia P Ouillette, R Collins, S Shakhan, J Li, C Li, K Shedden, SN Malek Clinical Cancer Research 17 (21), 6778-6790, 2011 | 136 | 2011 |
| Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia C Saddler, P Ouillette, L Kujawski, S Shangary, M Talpaz, M Kaminski, ... Blood, The Journal of the American Society of Hematology 111 (3), 1584-1593, 2008 | 132 | 2008 |
| Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia L Kujawski, P Ouillette, H Erba, C Saddler, A Jakubowiak, M Kaminski, ... Blood, The Journal of the American Society of Hematology 112 (5), 1993-2003, 2008 | 128 | 2008 |
| Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis CW Ross, PD Ouillette, CM Saddler, KA Shedden, SN Malek Clinical cancer research 13 (16), 4777-4785, 2007 | 127 | 2007 |
| Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 4.2020, NCCN clinical practice guidelines in oncology WG Wierda, JC Byrd, JS Abramson, SF Bilgrami, G Bociek, D Brander, ... Journal of the National Comprehensive Cancer Network 18 (2), 185-217, 2020 | 125 | 2020 |
| Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies LF Peterson, H Sun, Y Liu, H Potu, M Kandarpa, M Ermann, SM Courtney, ... Blood, The Journal of the American Society of Hematology 125 (23), 3588-3597, 2015 | 120 | 2015 |
| The B-cell-specific Src-family kinase Blk is dispensable for B-cell development and activation G Texido, I Su, I Mecklenbräuker, K Saijo, SN Malek, S Desiderio, ... Molecular and cellular biology 20 (4), 1227-1233, 2000 | 103 | 2000 |
| Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia J Long, B Parkin, P Ouillette, D Bixby, K Shedden, H Erba, S Wang, ... Blood, The Journal of the American Society of Hematology 116 (1), 71-80, 2010 | 99 | 2010 |
| Aggressive chronic lymphocytic leukemia with elevated genomic complexity is associated with multiple gene defects in the response to DNA double-strand breaks P Ouillette, S Fossum, B Parkin, L Ding, P Bockenstedt, A Al-Zoubi, ... Clinical Cancer Research 16 (3), 835-847, 2010 | 90 | 2010 |
